| Diagnosing missed cases of spinal muscular atrophy in genome, exome, and panel sequencing datasets |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Upregulation vs. loss of function of NTRK2 in 44 affected individuals leads to two distinct neurodevelopmental disorders |
|
|
|
|
|
|
|
|
|
| Correspondence on “Weighty matters: Considering the ethics of genetic risk scores for obesity” by C. Houtz |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| A systematic framework for selecting gene-condition pairs for inclusion in newborn sequencing panels: Early Check implementation |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Implementation of newborn screening for mucopolysaccharidosis type IVA and long-term monitoring in Taiwan |
|
|
|
|
|
|
|
|
|
| Deep phenotyping of 11 individuals with pathogenic variants in RNU4-2 reveals a clinically recognizable syndrome |
|
|
|
|
|
|
|
|
|
| Severe neurodevelopmental phenotype, diagnostic, and treatment challenges in patients with SECISBP2 deficiency |
|
|
|
|
|
|
|
|
|
| Group-based medical mistrust in genomic medicine: Associations with patient and provider perceptions of a specialty clinical encounter |
|
|
|
|
|
|
|
|
|
| A Genomic Counseling Model for Population-Based Sequencing: A Pre-Post Intervention Study |
|
|
|
|
|
|
|
|
|
| Clinical and genetic delineation of autosomal recessive and dominant ACTL6B-related developmental brain disorders |
|
|
|
|
|
|
|
|
|
| Persistent growth-promoting effects of vosoritide in children with achondroplasia are accompanied by improvements in physical and social aspects of health-related quality of life |
|
|
|
|
|
|
|
|
|
| Utilization of a SNP microarray to detect uniparental disomy: Implications and outcomes |
|
|
|
|
|
|
|
|
|
| Evaluation of Bayesian point-based system on the variant classification of hereditary cancer predisposition genes |
|
|
|
|
|
|
|
|
|
| Mapping the genetic landscape of treatable inherited metabolic disorders in a large Middle Eastern biobank |
|
|
|
|
|
|
|
|
|
| Ethical, legal, and social issues related to genetics and genomics in cancer: A scoping review and narrative synthesis |
|
|
|
|
|
|
|
|
|
| RPL26 variants: A rare cause of Diamond-Blackfan anemia syndrome with multiple congenital anomalies at the forefront |
|
|
|
|
|
|
|
|
|
| Functional characterization vs in silico prediction for TBX5 missense and splice variants in Holt-Oram syndrome |
|
|
|
|
|
|
|
|
|
| Advanced practice providers in the medical genetics workforce: A nationwide survey |
|
|
|
|
|
|
|
|
|
| Points to consider for providing expert witness testimony for the specialty of medical genetics: A statement of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Correspondence on “The Clinical Geneticist Workforce: Community Forums to Address Challenges and Opportunities” by Chung et al |
|
|
|
|
|
|
|
|
|
| Noncoding variants are a rare cause of recessive developmental disorders in trans with coding variants |
|
|
|
|
|
|
|
|
|
| The frequency and clinical impact of synonymous HTT loss-of-interruption and duplication-of-interruption variants in a diverse HD cohort |
|
|
|
|
|
|
|
|
|
| Measuring perceived utility of genomic sequencing: Development and validation of the GENEtic Utility (GENE-U) scale for adult screening |
|
|
|
|
|
|
|
|
|
| Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple café-au-lait macules |
|
|
|
|
|
|
|
|
|
| Large-scale genomic investigation of pediatric cholestasis reveals a novel hepatorenal ciliopathy caused by PSKH1 mutations |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Discovery of DNA methylation signature in the peripheral blood of individuals with history of antenatal exposure to valproic acid |
|
|
|
|
|
|
|
|
|
| Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene |
|
|
|
|
|
|
|
|
|
| Secondary ACMG and non-ACMG genetic findings in a multiethnic cohort of 16,713 pediatric participants |
|
|
|
|
|
|
|
|
|
| A national education program for rapid genomics in pediatric acute care: Building workforce confidence, competence, and capability |
|
|
|
|
|
|
|
|
|
| Assessment of the evidence yield for the calibrated PP3/BP4 computational recommendations |
|
|
|
|
|
|
|
|
|
| Disparities in access to reproductive genetic services associated with geographic location of residence and maternal race and ethnicity |
|
|
|
|
|
|
|
|
|
| Application of multiple mosaic callers improves post-zygotic mutation detection from exome sequencing data |
|
|
|
|
|
|
|
|
|
| Novel insights into the phenotypic spectrum and pathogenesis of Hardikar syndrome |
|
|
|
|
|
|
|
|
|
| Loss-of-function in RBBP5 results in a syndromic neurodevelopmental disorder associated with microcephaly |
|
|
|
|
|
|
|
|
|
| Refining the phenotype of SINO syndrome: A comprehensive cohort report of 14 novel cases |
|
|
|
|
|
|
|
|
|
| Clinical signatures of genetic epilepsies precede diagnosis in electronic medical records of 32,000 individuals |
|
|
|
|
|
|
|
|
|
| Correspondence on “The ClinGen Brain Malformation Variant Curation Expert Panel: Rules for somatic variants in AKT3, MTOR, PIK3CA, and PIK3R2” by Lai et al |
|
|
|
|
|
|
|
|
|
| A multicenter analysis of individuals with a 47,XXY/46,XX karyotype |
|
|
|
|
|
|
|
|
|
| Response to Horta et al |
|
|
|
|
|
|
|
|
|
| “The truth should not be hidden”: Experiences and recommendations of individuals making NPE discoveries through genetic genealogy databases |
|
|
|
|
|
|
|
|
|
| Response to Wei et al |
|
|
|
|
|
|
|
|
|
| Correspondence on “Comparison of literature mining tools for variant classification: Through the lens of 50 RYR1 variants” by Wermers et al |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Editorial board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| The Undiagnosed Diseases Network: Characteristics of solvable applicants and diagnostic suggestions for nonaccepted ones |
|
|
|
|
|
|
|
|
|
| Return of genetic research results in 21,532 individuals with autism |
|
|
|
|
|
|
|
|
|
| Identifying factors and causal chains associated with optimal implementation of Lynch syndrome tumor screening: An application of coincidence analysis |
|
|
|
|
|
|
|
|
|
| Considerations for reporting variants in novel candidate genes identified during clinical genomic testing |
|
|
|
|
|
|
|
|
|
| Attitudes, knowledge, and risk perceptions of patients who received elective genomic testing as a clinical service |
|
|
|
|
|
|
|
|
|
| Parents’ and patients’ perspectives, experiences, and preferences for germline genetic or genomic testing of children with cancer: A systematic review |
|
|
|
|
|
|
|
|
|
| Errors in genome sequencing result disclosures: A randomized controlled trial comparing neonatology non-genetics healthcare professionals and genetic counselors |
|
|
|
|
|
|
|
|
|
| Health-literate care organizations for precision health |
|
|
|
|
|
|
|
|
|
| Weighty matters: Considering the ethics of genetic risk scores for obesity |
|
|
|
|
|
|
|
|
|
| Response to Widen et al |
|
|
|
|
|
|
|
|
|
| Correspondence on “Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG)” by Grebe et al |
|
|
|
|
|
|
|
|
|
| “It’s hard to wait”: Provider perspectives on current genomic care in safety-net NICUs |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Editorial board |
|
|
|
|
|
|
|
|
|
| Analysis of financial barriers experienced by prospective genetic counseling students |
|
|
|
|
|
|
|
|
|
| Myotonic dystrophy type 1 testing, 2024 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Satisfaction with mode of delivery of genomic sequencing results in a diverse national sample of research participants through the Clinical Sequencing Evidence-Generating Research Consortium |
|
|
|
|
|
|
|
|
|
| Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: Lower rates for 5 years post chemotherapy |
|
|
|
|
|
|
|
|
|
| Validation of a clinical breast cancer risk assessment tool combining a polygenic score for all ancestries with traditional risk factors |
|
|
|
|
|
|
|
|
|
| Dominant missense variants in SREBF2 are associated with complex dermatological, neurological, and skeletal abnormalities |
|
|
|
|
|
|
|
|
|
| Laboratory testing for preconception/prenatal carrier screening: A technical standard of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Cancer risks for other sites in addition to breast in CHEK2 c.1100delC families |
|
|
|
|
|
|
|
|
|
| Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Where there is no genetic counselor: An online decision-aid supports the majority of parents’ diagnostic genomic testing choices for their children |
|
|
|
|
|
|
|
|
|
| Natural history of adults with KBG syndrome: A physician-reported experience |
|
|
|
|
|
|
|
|
|
| Heterogeneity of comprehensive clinical phenotype and longitudinal adaptive function and correlation with computational predictions of severity of missense genotypes in KIF1A-associated neurological d |
|
|
|
|
|
|
|
|
|
| Genome-wide epigenetic signatures facilitated the variant classification of the PURA gene and uncovered the pathomechanism of PURA-related neurodevelopmental disorders |
|
|
|
|
|
|
|
|
|
| Loss of function of FAM177A1, a Golgi complex localized protein, causes a novel neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| Genomic sequencing research in pediatric cancer care: Decision making, attitudes, and perceived utility among adolescents and young adults and their parents |
|
|
|
|
|
|
|
|
|
| Comparison of literature mining tools for variant classification: Through the lens of 50 RYR1 variants |
|
|
|
|
|
|
|
|
|
| Phenotypic and genetic spectra of galactose mutarotase deficiency: A nationwide survey conducted in Japan |
|
|
|
|
|
|
|
|
|
| Implementing evidence-based assertions of clinical actionability in the context of secondary findings: Updates from the ClinGen Actionability Working Group |
|
|
|
|
|
|
|
|
|
| All of Us participant perspectives on the return of value in research |
|
|
|
|
|
|
|
|
|
| Health care utilization and behavior changes after workplace genetic testing at a large US health care system |
|
|
|
|
|
|
|
|
|
| Correspondence on “Comparison of literature mining tools for variant classification: Through the lens of 50 RYR1 variants” by Wermers et al |
|
|
|
|
|
|
|
|
|
| Response to Kiel and Kozaric |
|
|
|
|
|
|
|
|
|
| A systematic review to assess the utility of genomic autopsy using exome or genome sequencing in cases of congenital anomalies and perinatal death |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Genetic research within Indigenous communities: Engagement opportunities and pathways forward |
|
|
|
|
|
|
|
|
|
| Measuring perceived utility of genomic sequencing: Development and validation of the GENEtic Utility (GENE-U) scale for pediatric diagnostic testing |
|
|
|
|
|
|
|
|
|
| GM1 gangliosidosis type II: Results of a 10-year prospective study |
|
|
|
|
|
|
|
|
|
| Biallelic loss-of-function variants of ZFTRAF1 cause neurodevelopmental disorder with microcephaly and hypotonia |
|
|
|
|
|
|
|
|
|
| Lethal phenotypes in Mendelian disorders |
|
|
|
|
|
|
|
|
|
| Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER |
|
|
|
|
|
|
|
|
|
| Addendum: Points to consider in the reevaluation and reanalysis of genomic test results: A statement of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Editorial board |
|
|
|
|
|
|
|
|
|
| Reconciling diversity in health and genomic data collection with the regulation of AI in clinical genomics |
|
|
|
|
|
|
|
|
|
| DISP1 deficiency: Monoallelic and biallelic variants cause a spectrum of midline craniofacial malformations |
|
|
|
|
|
|
|
|
|
| Results of inaugural international Down Syndrome Societal Services and Supports survey |
|
|
|
|
|
|
|
|
|
| Homozygous missense variants in YKT6 result in loss of function and are associated with developmental delay, with or without severe infantile liver disease and risk for hepatocellular carcinoma |
|
|
|
|
|
|
|
|
|
| Alleviating misclassified germline variants in underrepresented populations: A strategy using popmax |
|
|
|
|
|
|
|
|
|
| Cardiac phenotype in adolescents and young adults with long-chain 3-hydroxyacyl CoA dehydrogenase (LCHAD) deficiency |
|
|
|
|
|
|
|
|
|
| Genetics providers’ perspectives on the use of digital tools in clinical practice |
|
|
|
|
|
|
|
|
|
| The clinical geneticist workforce: Community forums to address challenges and opportunities |
|
|
|
|
|
|
|
|
|
| Guidance on Use of Race, Ethnicity, and Geographic Origin as Proxies for Genetic Ancestry Groups in Biomedical Publications |
|
|
|
|
|
|
|
|
|
| Biallelic USP14 variants cause a syndromic neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| A recurrent missense variant in the E3 ubiquitin ligase substrate recognition subunit FEM1B causes a rare syndromic neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders |
|
|
|
|
|
|
|
|
|
| Determining priority indicators of utility for genomic testing in rare disease: A Delphi study |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Exome and genome sequencing in a heterogeneous population of patients with rare disease: Identifying predictors of a diagnosis |
|
|
|
|
|
|
|
|
|
| Loss-of-function variants in UBAP1L cause autosomal recessive retinal degeneration |
|
|
|
|
|
|
|
|
|
| Improving access to exome sequencing in a medically underserved population through the Texome Project |
|
|
|
|
|
|
|
|
|
| Bi-allelic NIT1 variants cause a brain small vessel disease characterized by movement disorders, massively dilated perivascular spaces, and intracerebral hemorrhage |
|
|
|
|
|
|
|
|
|
| CIAO1 and MMS19 deficiency: A lethal neurodegenerative phenotype caused by cytosolic Fe-S cluster protein assembly disorders |
|
|
|
|
|
|
|
|
|
| Additional findings from the 100,000 Genomes Project: A qualitative study of recipient perspectives |
|
|
|
|
|
|
|
|
|
| Clinical utility of polygenic risk scores for embryo selection: A points to consider statement of the American College of Medical Genetics and Genomics (ACMG) |
|
|
|
|
|
|
|
|
|
| Section E6.7-6.12 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in solid tumors |
|
|
|
|
|
|
|
|
|
| Section E6.1–6.6 of the American College of Medical Genetics and Genomics (ACMG) Technical Laboratory Standards: Cytogenomic studies of acquired chromosomal abnormalities in neoplastic blood, bone mar |
|
|
|
|
|
|
|
|
|
| The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2 |
|
|
|
|
|
|
|
|
|
| Biallelic loss-of-function variants of SLC12A9 cause lysosome dysfunction and a syndromic neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| Addendum: Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Young adults with a 22q11.2 microdeletion and the cost of aging with complexity in a population-based context |
|
|
|
|
|
|
|
|
|
| Variants in UBAP1L lead to autosomal recessive rod-cone and cone-rod dystrophy |
|
|
|
|
|
|
|
|
|
| Chenodeoxycholic acid (CDCA) treatment during pregnancy in women with cerebrotendinous xanthomatosis (CTX): Lessons learned from 19 pregnancies |
|
|
|
|
|
|
|
|
|
| De novo variants in SP9 cause a novel form of interneuronopathy characterized by intellectual disability, autism spectrum disorder, and epilepsy with variable expressivity |
|
|
|
|
|
|
|
|
|
| Comparison of literature mining tools for variant classification: Through the lens of 50 RYR1 variants |
|
|
|
|
|
|
|
|
|
| Assessment of Mendelian and risk-factor genes in Alzheimer disease: A prospective nationwide clinical utility study and recommendations for genetic screening |
|
|
|
|
|
|
|
|
|
| Gene selection for genomic newborn screening: Moving toward consensus? |
|
|
|
|
|
|
|
|
|
| Diagnostic delay in monogenic disease: A scoping review |
|
|
|
|
|
|
|
|
|
| Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases |
|
|
|
|
|
|
|
|
|
| Narrowing the diagnostic gap: Genomes, episignatures, long-read sequencing, and health economic analyses in an exome-negative intellectual disability cohort |
|
|
|
|
|
|
|
|
|
| Correspondence on “Genotypic and phenotypic spectrum of infantile liver failure due to pathogenic TRMU variants” by Vogel et al |
|
|
|
|
|
|
|
|
|
| Response to Kulseth |
|
|
|
|
|
|
|
|
|
| A gene pathogenicity tool “GenePy” identifies missed biallelic diagnoses in the 100,000 Genomes Project |
|
|
|
|
|
|
|
|
|
| Correspondence on “Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)” |
|
|
|
|
|
|
|
|
|
| Improving care for rare genetic neurodevelopmental disorders: A systematic review and critical appraisal of clinical practice guidelines using AGREE II |
|
|
|
|
|
|
|
|
|
| Unbiased phenotype and genotype matching maximizes gene discovery and diagnostic yield |
|
|
|
|
|
|
|
|
|
| Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from Canada |
|
|
|
|
|
|
|
|
|
| Editorial Board |
|
|
|
|
|
|
|
|
|
| Table of Contents |
|
|
|
|
|
|
|
|
|
| Masthead |
|
|
|
|
|
|
|
|
|
| The cost of proband and trio exome and genome analysis in rare disease: A micro-costing study |
|
|
|
|
|
|
|
|
|
| Differential alternative splicing analysis links variation in ZRSR2 to a novel type of oral-facial-digital syndrome |
|
|
|
|
|
|
|
|
|
| Biallelic loss-of-function variants in CACHD1 cause a novel neurodevelopmental syndrome with facial dysmorphism and multisystem congenital abnormalities |
|
|
|
|
|
|
|
|
|
| Response to Stern |
|
|
|
|
|
|
|
|
|
| Molecular testing in newborn screening: VUS burden among true positives and secondary reproductive limitations via expanded carrier screening panels |
|
|
|
|
|
|
|
|
|
| Documentation of results and medication prescribing after combinatorial psychiatric pharmacogenetic testing: A case for discrete results |
|
|
|
|
|
|
|
|
|
| Characterization of central manifestations in patients with Niemann-Pick disease type C |
|
|
|
|
|
|
|
|
|
| DNA methylation episignature, extension of the clinical features, and comparative epigenomic profiling of Hao-Fountain syndrome caused by variants in USP7 |
|
|
|
|
|
|
|
|
|
| Secondary (additional) findings from the 100,000 Genomes Project: Disease manifestation, health care outcomes, and costs of disclosure |
|
|
|
|
|
|
|
|
|
| Expanding the genetic and phenotypic spectrum of ACTA2-related vasculopathies in a Dutch cohort |
|
|
|
|
|
|
|
|
|
| Most Fanconi anemia heterozygotes are not at increased cancer risk: A genome-first DiscovEHR cohort population study |
|
|
|
|
|
|
|
|
|
| Recommendations for risk allele evidence curation, classification, and reporting from the ClinGen Low Penetrance/Risk Allele Working Group |
|
|
|
|
|
|
|
|
|
| Severity-adjusted evaluation of liver transplantation on health outcomes in urea cycle disorders |
|
|
|
|
|
|
|
|
|
| Biallelic variants in SLC4A10 encoding a sodium-dependent bicarbonate transporter lead to a neurodevelopmental disorder |
|
|
|
|
|
|
|
|
|
| Sequential tumor molecular profiling identifies likely germline variants |
|
|
|
|
|
|
|
|
|
| Identification of DNA methylation episignature for the intellectual developmental disorder, autosomal dominant 21 syndrome, caused by variants in the CTCF gene |
|
|
|
|
|
|
|
|
|
| Clinical variants paired with phenotype: A rich resource for brain gene curation |
|
|
|
|
|
|
|
|
|
| Impact of genetic counseling strategy on diagnostic yield and workload for genome-sequencing-based tumor diagnostics |
|
|
|
|
|
|
|
|
|
| Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child? |
|
|
|
|
|
|
|
|
|
| Toward robust clinical genome interpretation: Developing a consistent terminology to characterize Mendelian disease-gene relationships—allelic requirement, inheritance modes, and disease mechanisms |
|
|
|
|
|
|
|
|
|
| Monogenic etiologies of persistent human papillomavirus infections: A comprehensive systematic review |
|
|
|
|
|
|
|
|
|
| Neurological manifestations in PMM2-congenital disorders of glycosylation (PMM2-CDG): Insights into clinico-radiological characteristics, recommendations for follow-up, and future directions |
|
|
|
|
|
|
|
|
|
| Biallelic CRELD1 variants cause a multisystem syndrome, including neurodevelopmental phenotypes, cardiac dysrhythmias, and frequent infections |
|
|
|
|
|
|
|
|
|
| Evaluation of the diagnostic accuracy of exome sequencing and its impact on diagnostic thinking for patients with rare disease in a publicly funded health care system: A prospective cohort study |
|
|
|
|
|
|
|
|
|
| De novo variants in RNF213 are associated with a clinical spectrum ranging from Leigh syndrome to early-onset stroke |
|
|
|
|
|
|
|
|
|
| Physician services and costs after disclosure of diagnostic sequencing results in the NYCKidSeq program |
|
|
|
|
|
|
|
|
|
| Genome sequencing detects a wide range of clinically relevant copy-number variants and other genomic alterations |
|
|
|
|
|
|
|
|
|
| Clinico-biological refinement of BCL11B-related disorder and identification of an episignature: A series of 20 unreported individuals |
|
|
|
|
|
|
|
|
|
| Ready or not, genomic screening of fetuses is already here |
|
|
|
|
|
|
|
|
|
| Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina |
|
|
|
|
|
|
|
|
|
| DLG2 intragenic exonic deletions reinforce the link to neurodevelopmental disorders and suggest a potential association with congenital anomalies and dysmorphism |
|
|
|
|
|
|
|
|
|
| Evidence from 2100 index cases supports genome sequencing as a first-tier genetic test |
|
|
|
|
|
|
|
|
|
| The Parent PrU: A measure to assess personal utility of pediatric genomic results |
|
|
|
|
|
|
|
|
|
| Views of adults living with sickle cell disease on the theoretical return of secondary genomic findings |
|
|
|
|
|
|
|
|
|
| Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel |
|
|
|
|
|
|
|
|
|
| Preparing for the unexpected: Recommendations for returning secondary findings in late-stage cancer care |
|
|
|
|
|
|
|
|
|
| Response to Lombardi and Mesnard |
|
|
|
|
|
|
|
|
|
| Incidence, prevalence, age at diagnosis, and mortality in individuals with 45,X/46,XY mosaicism: A population-based registry study |
|
|
|
|
|
|
|
|
|
| Correspondence on “Genomic testing for suspected monogenic kidney disease in children and adults: A health economic evaluation” by Wu et al |
|
|
|
|
|
|
|
|
|
| Systematic evidence review and meta-analysis of outcomes associated with cancer genetic counseling |
|
|
|
|
|
|
|
|
|
| Rare-variant and polygenic analyses of amyotrophic lateral sclerosis in the French-Canadian genome |
|
|
|
|
|
|
✓ |
|
French-Canadian |